Colorado University to trial Mesoblast's stem cells for bone regeneration (PharmaBiz)

Australia's adult stem cell company, Mesoblast Limited has entered into agreements with Colorado State University to perform preclinical dose-escalation trials of its proprietary, universal donor adult stem cell technology for the treatment of long bone fractures, and for a new indication, intervertebral spinal fusion.
cave colorado spring